£88m Series B For Syncona-backed Freeline To Advance Liver Gene Therapy Focus

 
• By Sten Stovall
Dollar boat
Freeline's Series B Financing Refloats Gene Therapy Specialist • Source: Shutterstock

More from Financing

More from Business